Adverse event,
n (%)

Sugammadex 4.0 mg/kg
(n=51)

Neostigmine 50 μg/kg (n=49)

Procedural pain

41 (80.4)

38 (77.6)

Nausea

26 (51.0)

24 (49.0)

Vomiting

9 (17.6)

11 (22.4)

Incision-site pain

7 (13.7)

9 (18.4)

Constipation

6 (11.8)

6 (12.2)

Headache

3 (5.9)

7 (14.3)

Pyrexia

7 (13.7)

2 (4.1)

Dizziness

6 (11.8)

2 (4.1)

Pruritus

3 (5.9)

5 (10.2)
Table 4: Adverse events occurring in at least 10% of patients in either treatment group, regardless of relationship to study drug (all-subjects-treated group, n=100).